Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HEY2 antisense RNA 1 (HEY2-AS1) is a long non-coding RNA (lncRNA), transcribed from the genome in an antisense orientation to the HEY2 gene, located on chromosome 6 (human genome hg38: chr6:125577545-125749190). As an antisense RNA, it likely acts to regulate the expression of the nearby HEY2 gene by mechanisms typical for natural antisense RNAs, which may include chromatin remodeling, transcriptional interference, RNA duplex formation to stabilize or destabilize sense transcripts, or other forms of post-transcriptional regulation. There is currently little direct evidence that HEY2-AS1 itself is a therapeutic target, or that it is implicated in specific disease mechanisms in the way that more widely studied antisense RNAs (such as HAS2-AS1 or HAND2-AS1) are. No drug interactions, biomarker roles, mechanisms of pharmacological action, or significant therapeutic safety concerns have been described for HEY2-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HEY2 antisense RNA 1 (HEY2-AS1).